Centrum Medyczne ENEL-MED S.A.(PL:ENE)
zł 19.90+-0.10 (+3.11%)
PL:ENE
Centrum Medyczne ENEL-MED S.A. financials statements
zł 19.90
At close:+-0.10 (+3.11%)
Centrum Medyczne ENEL-MED S.A. (ENE) Ratios
1 Followers
Centrum Medyczne ENEL-MED S.A. Ratios
PL:ENE's free cash flow for Q2 2026 was zł-5.36M. For the 2026 fiscal year, PL:ENE's free cash flow was decreased by zł-21.25M and operating cash flow was zł15.89M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.60 | 0.66 | 0.48 | 0.57 | 1.11 |
| Quick Ratio | 0.58 | 0.62 | 0.45 | 0.54 | 1.08 |
| Cash Ratio | 0.20 | 0.29 | 0.25 | 0.22 | 0.79 |
| Solvency Ratio | 0.21 | 0.25 | 0.25 | 0.14 | 0.21 |
| Operating Cash Flow Ratio | 0.60 | 0.79 | 0.60 | 0.38 | 0.71 |
| Short-Term Operating Cash Flow Coverage | 22.15 | 52.79 | 4.99 | 5.45 | 9.33 |
| Net Current Asset Value | zł -355.68M | zł -278.28M | zł -250.84M | zł -220.42M | zł -160.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.51 | 0.50 | 0.50 | 0.45 |
| Debt-to-Equity Ratio | 1.84 | 1.59 | 1.47 | 1.43 | 1.13 |
| Debt-to-Capital Ratio | 0.65 | 0.61 | 0.60 | 0.59 | 0.53 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.04 | 0.00 | 0.01 | 0.02 |
| Financial Leverage Ratio | 3.45 | 3.11 | 2.97 | 2.84 | 2.50 |
| Debt Service Coverage Ratio | 6.71 | 8.12 | 3.42 | 3.37 | 4.77 |
| Interest Coverage Ratio | 2.00 | 2.68 | 0.30 | -3.58 | 0.81 |
| Debt to Market Cap | 0.04 | 0.02 | 0.03 | 0.02 | 0.03 |
| Interest Debt Per Share | 12.44 | 10.09 | 8.69 | 7.92 | 8.52 |
| Net Debt to EBITDA | 3.02 | 2.26 | 2.21 | 4.87 | 1.97 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.32% | 7.95% | 4.20% | 2.20% | 5.03% |
| EBIT Margin | 2.39% | 4.02% | 3.19% | -4.47% | 1.33% |
| EBITDA Margin | 11.95% | 14.28% | 14.73% | 8.08% | 14.35% |
| Operating Profit Margin | 2.39% | 3.80% | 0.48% | -4.21% | 1.06% |
| Pretax Profit Margin | 1.91% | 2.60% | 1.59% | -5.65% | 0.02% |
| Net Profit Margin | 1.51% | 1.99% | 1.33% | -4.76% | -0.32% |
| Continuous Operations Profit Margin | 1.51% | 1.99% | 1.28% | -4.76% | -0.32% |
| Net Income Per EBT | 79.05% | 76.32% | 83.88% | 84.31% | -1468.75% |
| EBT Per EBIT | 79.82% | 68.50% | 328.42% | 134.07% | 2.05% |
| Return on Assets (ROA) | 2.01% | 2.72% | 1.73% | -5.45% | -0.32% |
| Return on Equity (ROE) | 6.94% | 8.46% | 5.13% | -15.50% | -0.80% |
| Return on Capital Employed (ROCE) | 4.29% | 6.88% | 0.88% | -6.36% | 1.35% |
| Return on Invested Capital (ROIC) | 3.03% | 4.72% | 0.65% | -4.67% | -17.75% |
| Return on Tangible Assets | 2.08% | 2.83% | 1.81% | -5.72% | -0.33% |
| Earnings Yield | 2.65% | 2.56% | 1.53% | -5.31% | -0.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.40 | 17.66 | 19.32 | 18.30 | 19.42 |
| Payables Turnover | 10.04 | 11.19 | 10.64 | 13.19 | 12.95 |
| Inventory Turnover | 172.87 | 153.57 | 136.86 | 137.16 | 139.09 |
| Fixed Asset Turnover | 1.67 | 1.76 | 1.70 | 1.45 | 1.40 |
| Asset Turnover | 1.33 | 1.37 | 1.30 | 1.15 | 1.00 |
| Working Capital Turnover Ratio | -15.53 | -12.73 | -10.69 | -29.16 | -29.48 |
| Cash Conversion Cycle | -10.53 | -9.58 | -12.76 | -5.06 | -6.76 |
| Days of Sales Outstanding | 23.71 | 20.67 | 18.89 | 19.94 | 18.79 |
| Days of Inventory Outstanding | 2.11 | 2.38 | 2.67 | 2.66 | 2.62 |
| Days of Payables Outstanding | 36.35 | 32.63 | 34.32 | 27.66 | 28.18 |
| Operating Cycle | 25.82 | 23.05 | 21.56 | 22.60 | 21.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.51 | 3.65 | 2.86 | 1.42 | 2.79 |
| Free Cash Flow Per Share | 0.77 | 2.06 | 1.71 | -0.21 | 1.19 |
| Dividend Paid and CapEx Coverage Ratio | 1.28 | 2.30 | 2.47 | 0.87 | 1.74 |
| Capital Expenditure Coverage Ratio | 1.28 | 2.30 | 2.47 | 0.87 | 1.74 |
| Operating Cash Flow Coverage Ratio | 0.29 | 0.38 | 0.34 | 0.18 | 0.34 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.14 | 0.13 | 0.08 | 0.15 |
| Free Cash Flow Yield | 4.48% | 10.21% | 8.98% | -1.33% | 6.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.39 | 38.85 | 65.30 | -18.85 | -302.00 |
| Price-to-Sales (P/S) Ratio | 0.57 | 0.78 | 0.87 | 0.90 | 0.97 |
| Price-to-Book (P/B) Ratio | 2.62 | 3.31 | 3.35 | 2.92 | 2.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.32 | 9.79 | 11.13 | -75.28 | 14.92 |
| Price-to-Operating Cash Flow Ratio | 4.89 | 5.53 | 6.63 | 11.09 | 6.34 |
| Price-to-Earnings Growth (PEG) Ratio | -3.24 | 0.49 | -0.48 | -0.01 | 5.19 |
| Enterprise Value Multiple | 7.78 | 7.70 | 8.11 | 15.97 | 8.69 |
| Enterprise Value | 794.27M | 808.97M | 739.04M | 638.65M | 550.28M |
| EV to EBITDA | 7.78 | 7.70 | 8.11 | 15.97 | 8.69 |
| EV to Sales | 0.93 | 1.10 | 1.19 | 1.29 | 1.25 |
| EV to Free Cash Flow | 36.44 | 13.87 | 15.31 | -108.28 | 19.28 |
| EV to Operating Cash Flow | 7.99 | 7.83 | 9.12 | 15.95 | 8.19 |
| Tangible Book Value Per Share | 5.84 | 5.36 | 4.92 | 4.66 | 6.73 |
| Shareholders’ Equity Per Share | 6.57 | 6.11 | 5.67 | 5.38 | 7.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.24 | 0.16 | 0.16 | 15.69 |
| Revenue Per Share | 30.21 | 26.01 | 21.87 | 17.50 | 18.34 |
| Net Income Per Share | 0.46 | 0.52 | 0.29 | -0.83 | -0.06 |
| Tax Burden | 0.79 | 0.76 | 0.84 | 0.84 | -14.69 |
| Interest Burden | 0.80 | 0.65 | 0.50 | 1.26 | 0.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.05 | 0.05 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 7.71 | 5.39 | 9.85 | -1.43 | 108.69 |
Currency in PLN
